Lupin Limited
Read Time:13 Second
Lupin Limited has informed the Exchange regarding a press release dated November 14, 2025, titled “Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere”. |SUBJECT: Press Release
Happy
0
0 %
Sad
0
0 %
Excited
0
0 %
Sleepy
0
0 %
Angry
0
0 %
Surprise
0
0 %
More Stories
Bhagiradha Chemicals & Industries Limited
Bhagiradha Chemicals & Industries Limited has informed the Exchange regarding 'Intimation under Regulation 30 of the SEBI (Listing Obligations and...
HFCL Limited
HFCL Limited has informed the Exchange about Sale of HFCL Limited s Thermal Weapon Sights ( TWS ) business to...
Oil & Natural Gas Corporation Limited
Oil & Natural Gas Corporation Limited has informed the Exchange about Corrigendum in respect of Announcement Appointment of Director (Finance)...
HFCL Limited
HFCL Limited has informed the Exchange about Sale of up to 80% of the paid-up share capital of Raddef Private...
Amit Spinning Industries Limited
Amit Spinning Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. |SUBJECT:...
Akums Drugs and Pharmaceuticals Limited
Intimation of Schedule of the Investor/Analysts Meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Average Rating